-
Loading metrics
Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial
-
Hanako Ohashi Ikeda ,
Roles Conceptualization, Funding acquisition, Writing – original draft
* E-mail: hanakoi@kuhp.kyoto-u.ac.jp
Affiliations Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
⨯ - Yuki Muraoka,
- Masayuki Hata,
- Eriko Sumi,
- Takafumi Ikeda,
- Takayuki Nakagawa,
- Hiroyasu Abe,
- Harue Tada,
- Satoshi Morita,
- Akira Kakizuka,
- Nagahisa Yoshimura,
- Akitaka Tsujikawa
http://orcid.org/0000-0001-9572-8659
Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial
- Hanako Ohashi Ikeda,
- Yuki Muraoka,
- Masayuki Hata,
- Eriko Sumi,
- Takafumi Ikeda,
- Takayuki Nakagawa,
- Hiroyasu Abe,
- Harue Tada,
- Satoshi Morita,
- Akira Kakizuka
x
- Published: February 13, 2020
- https://doi.org/10.1371/journal.pone.0229068